Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk's blockbuster diabetes drug blows the doors off in obesity, proving highly effective in driving weight loss
Endpoints
Thu, 02/11/21 - 10:43 am
Tags:
Novo Nordisk, semaglutide, obesity
Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral meds
Fierce Pharma
Thu, 02/4/21 - 10:43 am
Tags:
Novo Nordisk, drug manufacturing, APIs
Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes
Yahoo/Global Newswire
Wed, 01/20/21 - 10:39 am
Tags:
Novo Nordisk, FDA, Ozempic, type 2 diabetes, semaglutide
Pharma TV ad spenders blow up December with spendiest month of 2020
Fierce Pharma
Wed, 01/6/21 - 10:50 am
Tags:
television ads, AbbVie, Humira, Novo Nordisk, DTC ads
Novo Nordisk’s gene silencing alliance with Dicerna bears first fruit
Pharmaforum
Wed, 01/6/21 - 10:42 am
Tags:
Novo Nordisk, Dicerna, gene silencing, liver disease
Novo takes the plunge in Alzheimer’s
EP Vantage
Thu, 12/17/20 - 06:20 pm
Tags:
Novo Nordisk, Rybelsus, Alzheimer's disease
Novo invests in Hemab, a company going against the hemophilia gene therapy grain with a plan for bispecifics
Endpoints
Mon, 12/14/20 - 10:53 am
Tags:
Novo Nordisk, Novo Holdings, Hemab, hemophilia
Novo Nordisk to end 340B discounts on drugs dispensed at community pharmacies
Beckers Hospital Review
Tue, 12/8/20 - 11:10 pm
Tags:
Novo Nordisk, 340B, hospitals
Gilead and Novo plot next steps after trial data from NASH combo
Pharmaforum
Mon, 11/16/20 - 10:19 am
Tags:
Gilead Sciences, Novo Nordisk, NASH, clinical trials, semaglutide, cilofexor, firsocostat
Novo Nordisk to boost pill-form diabetic drugs with $1.8 billion deal
Reuters
Fri, 11/6/20 - 10:40 am
Tags:
Novo Nordisk, M&A, Emisphere, pill technology, diabetes
AASLD 2020 – Nash updates from Novo and Inventiva in focus
EP Vantage
Wed, 11/4/20 - 10:09 am
Tags:
NASH, Novo Nordisk, Gilead Sciences, Inventiva, AASLD, selonsertib
Novo Nordisk quietly nabs a rare 'breakthrough' status in NASH for its cash cow
Endpoints
Fri, 10/30/20 - 10:25 am
Tags:
Novo Nordisk, earnings, NASH, semaglutide, breakthrough therapy, FDA
Novo Nordisk scraps Type 1 diabetes drug after phase 2 trial
Fierce Biotech
Fri, 10/30/20 - 10:16 am
Tags:
Novo Nordisk, NN9828, Victoza, clinical trials, type 1 diabetes
Heart to heart: Novo Nordisk teams with ACC to open diabetes discussion
Fierce Pharma
Mon, 09/28/20 - 10:39 am
Tags:
Novo Nordisk, pharma marketing, American College of Cardiology, patients, cardiovascular disease
Novo adds weight to its obesity goals
EP Vantage
Thu, 09/10/20 - 10:17 am
Tags:
Novo Nordisk, semaglutide, obesity
Novo launches type 2 diabetes pill in UK after NICE waives review
Pharmaforum
Tue, 09/1/20 - 10:44 am
Tags:
Novo Nordisk, UK, type 2 diabetes, diabetes, Rybelsus, semaglutide, NICE
How did Novo Nordisk's Sophia chatbot become a pharma industry standard? Empathy, timing and relevance: experts
Fierce Pharma
Tue, 08/18/20 - 11:08 pm
Tags:
Novo Nordisk, chatbot, digital pharma, Sophia
Novo Nordisk taps Evotec to target chronic kidney disease
Fierce Biotech
Tue, 08/18/20 - 11:14 am
Tags:
Novo Nordisk, chronic kidney disease, Evotec
Novo gets PhIII hemophilia trials for a Roche rival back on track after completing work-around on blood clot threat
Endpoints
Thu, 08/13/20 - 09:48 am
Tags:
Novo Nordisk, hemophilia, concizumab, clinical trials
Novo backs 'breakthrough' antifungal player's $60M round — with a focus on rare mold infections
Endpoints
Wed, 08/12/20 - 10:34 am
Tags:
drug development, antibiotics, F2G, Novo Nordisk

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.